A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Bin ZhangYuemang YaoAnne-Sophie CornecKillian OukoloffMichael J JamesPyry KoivulaJohn Q TrojanowskiAmos B SmithVirginia M-Y LeeCarlo BallatoreKurt R BrundenPublished in: Molecular neurodegeneration (2018)
A brain-penetrant MT-stabilizing TPD can safely correct MT and axonal deficits in an established mouse model of tauopathy, resulting in reduced tau pathology.